What's happening in cancer biology?

I find and read the latest resarch, trying to make sense of what it means and where we might be going.

How Scientists Are Using Living Micro-Robots to Fight Cancer

Mobile microrobots, which can be remotely controlled inside the body, have emerged as a promising new cancer therapeutic approach that could overcome limitations associated with traditional systemic administration methods1. However, because these microrobots were formerly produced from synthetic materials, they can induce unwanted immune responses due to the introduction of a foreign body into the organism.

May 9, 2026

Eat more plants! Equipping T cells to utilize the plant metabolite cellobiose in the glucose depleted tumor microenvironment.

Tumor cells greatly increase their glucose consumption to support their high metabolic demands. Unfortunately, infiltrating immune cells such as cytotoxic T cells also undergo metabolic reprogramming when activated, and require glucose to elicit their effector functions in the tumor.

March 31, 2026

A Partnership Between Tumor Cells and Macrophages Drives Breast Cancer Metastasis

Cancer cells within a tumor are not uniform and display marked differences in their molecular and phenotypic characteristics, termed. . .

March 5, 2026

Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial

Breast cancer is the most common cancer in women worldwide, and while detection of early-stage disease is largely curable, between 20-30% of patients will relapse to develop distant, incurable, metastatic disease years, or even decades, following successful treatment.

February 26, 2026

A crucial role of the PD-1 axis in survival and clonal selection of stem-like CD8+ T cells

For cancer cells to successfully establish and grow, they must overcome immune surveillance and immune mediated destruction. One crucial arm of the immune system, cytotoxic T lymphocytes, or CD8+ T cells, are critical players in tumor control.